Friday, April 15, 2016

BRIEF-EMA'S PRAC extends safety review of chronic Hep C treatments

* Started review of diabetes medicine canagliflozin after

increase in amputations in ongoing trial

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)